P386 Health outcomes for PwCF switching from a CFTR modulator therapy (CFTRm) to elexaftor/tezacaftor/ivacaftor (ETI) compared with those starting on ETI naively. A study using Irish registry data
P. O’Regan(University College Cork), L. Kirwan(Cystic Fibrosis Ireland), S. Joshy(Cystic Fibrosis Ireland), R. Doherty(Cystic Fibrosis Ireland), G. Fletcher(Cystic Fibrosis Ireland)
Cited by 0
Related Papers
A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive disorder
|Systematic Reviews|2018|15
Computed tomography in constrictive pericarditis.
|PubMed|1984|3
Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation
|Children|2024|3
Radiology of the Mesentery
|Clinics in Colon and Rectal Surgery|2022|2